Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum–Induced Apoptosis in Endothelial Progenitor Cells

Background— Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the unde...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 118; no. 21; pp. 2156 - 2165
Main Authors Zhu, Shoukang, Evans, Sarah, Yan, Bin, Povsic, Thomas J., Tapson, Victor, Goldschmidt-Clermont, Pascal J., Dong, Chunming
Format Journal Article
LanguageEnglish
Published United States 18.11.2008
Subjects
Online AccessGet full text
ISSN0009-7322
1524-4539
1524-4539
DOI10.1161/CIRCULATIONAHA.108.787200

Cover

Abstract Background— Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was. Methods and Results— Circulating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum–induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects. Conclusion— Scleroderma serum–induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients.
AbstractList Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was. Circulating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum-induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects. Scleroderma serum-induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients.
Background— Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was. Methods and Results— Circulating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum–induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects. Conclusion— Scleroderma serum–induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients.
Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was.BACKGROUNDEndothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was.Circulating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum-induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects.METHODS AND RESULTSCirculating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum-induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects.Scleroderma serum-induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients.CONCLUSIONSScleroderma serum-induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients.
Author Zhu, Shoukang
Povsic, Thomas J.
Dong, Chunming
Yan, Bin
Tapson, Victor
Evans, Sarah
Goldschmidt-Clermont, Pascal J.
AuthorAffiliation Miller School of Medicine, University of Miami, Miami, FL 33101
Department of Medicine, Duke University Medical Center, Durham, NC 27710
AuthorAffiliation_xml – name: Department of Medicine, Duke University Medical Center, Durham, NC 27710
– name: Miller School of Medicine, University of Miami, Miami, FL 33101
Author_xml – sequence: 1
  givenname: Shoukang
  surname: Zhu
  fullname: Zhu, Shoukang
  organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.)
– sequence: 2
  givenname: Sarah
  surname: Evans
  fullname: Evans, Sarah
  organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.)
– sequence: 3
  givenname: Bin
  surname: Yan
  fullname: Yan, Bin
  organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.)
– sequence: 4
  givenname: Thomas J.
  surname: Povsic
  fullname: Povsic, Thomas J.
  organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.)
– sequence: 5
  givenname: Victor
  surname: Tapson
  fullname: Tapson, Victor
  organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.)
– sequence: 6
  givenname: Pascal J.
  surname: Goldschmidt-Clermont
  fullname: Goldschmidt-Clermont, Pascal J.
  organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.)
– sequence: 7
  givenname: Chunming
  surname: Dong
  fullname: Dong, Chunming
  organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18981303$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1u1DAUhS1URKeFV0Bmwy6Df8aJswFNo5aONDConUrsIse-mRoSO9gJUneIV-ANeRJcpvyUFSv72t8959rnCB047wChZ5TMKc3pi2p1UV2tl9vV5u3yfDmnRM4LWTBCHqAZFWyRLQQvD9CMEFJmBWfsEB3F-CGVOS_EI3RIZSkpJ3yGvm6DclEHO4zWO9XhC9hNnbotsG_xie1xc4PPNu83XGHlDF5-HPEbMFaNEPGl7iB4A6FX-BLC1H__8m3lzKQhgYMfRh9txNbhU2f8eA2dTQ7vgt-Bs6MPuIKui4_Rw1Z1EZ7crcfo6ux0W51n683rVbVcZ1oQMWYN47lkijJWiDzn1GjJSAFUGqEEKQk0SuYLk3aiBQKFEZwLxiVrG61zaPgxernXHaamB6PBjUF19RBsr8JN7ZWt7984e13v_OeaF7QklCSB53cCwX-aII51b6NOT1AO_BTrvJQkDckS-PRvp98Wv749AeUe0MHHGKD9g5D6NuL6fsTpWNb7iFPvq396tR1_BpaGtt1_KPwAjqOyQg
CitedBy_id crossref_primary_10_1183_09059180_00003214
crossref_primary_10_1136_annrheumdis_2011_200713
crossref_primary_10_1182_blood_2013_10_530964
crossref_primary_10_3390_ijms241814385
crossref_primary_10_1002_art_24921
crossref_primary_10_1002_cbin_11016
crossref_primary_10_1038_nrrheum_2009_81
crossref_primary_10_1016_j_jid_2016_08_027
crossref_primary_10_1016_j_revmed_2019_05_016
crossref_primary_10_1016_j_vph_2015_05_015
crossref_primary_10_4049_jimmunol_2000971
crossref_primary_10_1016_j_mvr_2015_01_004
crossref_primary_10_1371_journal_pone_0101703
crossref_primary_10_1097_BOR_0b013e3283328098
crossref_primary_10_1002_jcp_24938
crossref_primary_10_1016_j_cellsig_2018_08_009
crossref_primary_10_1155_2014_972043
crossref_primary_10_1007_s11883_012_0244_1
crossref_primary_10_3389_fimmu_2018_01383
crossref_primary_10_1007_s12015_023_10617_y
crossref_primary_10_1155_2010_362868
crossref_primary_10_1158_0008_5472_CAN_10_3253
crossref_primary_10_4049_jimmunol_1601968
crossref_primary_10_3389_fimmu_2015_00272
crossref_primary_10_1016_j_autrev_2024_103540
crossref_primary_10_1111_cpr_12962
crossref_primary_10_1002_art_40505
crossref_primary_10_1016_j_autrev_2017_05_024
crossref_primary_10_1074_jbc_M111_221697
crossref_primary_10_1111_1756_185X_12487
crossref_primary_10_1016_j_ijbiomac_2018_05_174
crossref_primary_10_3390_ph16060906
crossref_primary_10_1186_s13075_017_1271_7
crossref_primary_10_1038_nrrheum_2010_102
crossref_primary_10_1016_j_mvr_2013_07_009
crossref_primary_10_1038_s41392_018_0026_5
crossref_primary_10_1186_ar3180
crossref_primary_10_1002_jcb_28801
crossref_primary_10_1186_ar3069
crossref_primary_10_5301_jsrd_5000217
crossref_primary_10_1007_s12031_013_0111_8
crossref_primary_10_1155_2011_495792
crossref_primary_10_1093_rheumatology_kev399
crossref_primary_10_1371_journal_pone_0031226
crossref_primary_10_1002_art_30361
crossref_primary_10_1186_s12882_015_0064_y
crossref_primary_10_1002_cbin_11887
crossref_primary_10_3390_biomedicines9070847
crossref_primary_10_1159_000444517
crossref_primary_10_1111_j_1471_4159_2009_06043_x
crossref_primary_10_1111_j_1582_4934_2010_01027_x
crossref_primary_10_2174_1871520620666200627204857
crossref_primary_10_3899_jrheum_091346
crossref_primary_10_1016_j_autrev_2011_04_016
crossref_primary_10_1016_j_jsbmb_2017_07_005
crossref_primary_10_1155_2017_8208065
crossref_primary_10_1007_s10495_015_1126_0
Cites_doi 10.1056/NEJMoa022287
10.1161/01.cir.0000082924.75945.48
10.1007/s10067-004-0987-3
10.1371/journal.pmed.0020354
10.1136/ard.2007.082131
10.1096/fj.04-2727fje
10.1002/art.1780230510
10.1186/ar2165
10.1016/S0140-6736(04)16864-5
10.1002/art.22035
10.1016/j.ejphar.2007.01.045
10.1126/science.275.5302.964
10.2217/14796694.2.1.83
10.1007/s11926-008-0031-8
10.1002/art.21952
10.1161/01.atv.0000114236.77009.06
10.1016/j.radonc.2006.07.021
10.1074/jbc.M304736200
10.1002/art.11310
10.1007/s12016-007-8009-2
10.1016/S0140-6736(04)16853-0
10.1038/sj.onc.1208421
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1161/CIRCULATIONAHA.108.787200
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage 2165
ExternalDocumentID PMC3719010
18981303
10_1161_CIRCULATIONAHA_108_787200
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: AG023073
– fundername: NIA NIH HHS
  grantid: R01 AG023073
– fundername: National Institute on Aging : NIA
  grantid: R01 AG023073 || AG
GroupedDBID ---
.-D
.3C
.55
.XZ
.Z2
01R
0R~
0ZK
18M
1J1
29B
2FS
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAEJM
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AARTV
AASOK
AAUEB
AAWTL
AAXQO
AAYOK
AAYXX
ABBUW
ABDIG
ABJNI
ABOCM
ABPMR
ABPXF
ABQRW
ABXVJ
ABZAD
ACCJW
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACOAL
ACRKK
ACWDW
ACWRI
ACXNZ
ACZKN
ADBBV
ADCYY
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFCHL
AFDTB
AFEXH
AFFNX
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJJEV
AJNWD
AJNYG
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
ASPBG
AVWKF
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C1A
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GX1
H0~
H13
HZ~
H~9
IKREB
IKYAY
IN~
J5H
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
M18
N9A
NEJ
N~7
N~B
O9-
OAG
OAH
OBH
OCB
OCUKA
ODMTH
OGEVE
OHH
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RLZ
S4R
S4S
T8P
TEORI
TR2
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
YSK
YYM
YZZ
ZFV
ZY1
ZZMQN
~H1
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADKSD
5PM
ID FETCH-LOGICAL-c505t-b23682a122756631dc8207e18d5a5090eba864d0905fe0e7d53352382fbcc6eb3
ISSN 0009-7322
1524-4539
IngestDate Thu Aug 21 13:34:11 EDT 2025
Sun Sep 28 01:33:36 EDT 2025
Mon Jul 21 06:05:55 EDT 2025
Thu Apr 24 22:56:24 EDT 2025
Tue Jul 01 02:05:32 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 21
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c505t-b23682a122756631dc8207e18d5a5090eba864d0905fe0e7d53352382fbcc6eb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 18981303
PQID 69802362
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3719010
proquest_miscellaneous_69802362
pubmed_primary_18981303
crossref_primary_10_1161_CIRCULATIONAHA_108_787200
crossref_citationtrail_10_1161_CIRCULATIONAHA_108_787200
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-11-18
PublicationDateYYYYMMDD 2008-11-18
PublicationDate_xml – month: 11
  year: 2008
  text: 2008-11-18
  day: 18
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2008
References e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
(e_1_3_2_10_2) 1988; 15
e_1_3_2_1_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_22_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_23_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
14613262 - Arthritis Rheum. 2003 Nov;48(11):3023-30
15349798 - Clin Rheumatol. 2005 Apr;24(2):111-6
16250671 - PLoS Med. 2005 Dec;2(12):e354
17767740 - Arthritis Res Ther. 2007;9 Suppl 2:S2
16868984 - Arthritis Rheum. 2006 Aug;54(8):2605-15
12860902 - Circulation. 2003 Jul 29;108(4):457-63
12584367 - N Engl J Med. 2003 Feb 13;348(7):593-600
27161125 - Acta Haematol. 2016;136(2):65-70
15313361 - Lancet. 2004 Aug 14-20;364(9434):603-10
16802364 - Arthritis Rheum. 2006 Jul;54(7):2250-62
15688014 - Oncogene. 2005 Mar 31;24(14):2317-29
17320859 - Eur J Pharmacol. 2007 May 7;562(1-2):111-8
16556075 - Future Oncol. 2006 Feb;2(1):83-9
18064573 - Clin Rev Allergy Immunol. 2007 Oct;33(1-2):107-12
15313340 - Lancet. 2004 Aug 14-20;364(9434):561-2
14551207 - J Biol Chem. 2004 Jan 9;279(2):1513-25
16916558 - Radiother Oncol. 2006 Aug;80(2):199-206
18174219 - Ann Rheum Dis. 2008 Oct;67(10):1455-60
14699017 - Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):288-93
18638425 - Curr Rheumatol Rep. 2008 Jul;10(3):183-8
7378088 - Arthritis Rheum. 1980 May;23(5):581-90
9020076 - Science. 1997 Feb 14;275(5302):964-7
15824087 - FASEB J. 2005 Jun;19(8):974-6
3361530 - J Rheumatol. 1988 Feb;15(2):202-5
References_xml – ident: e_1_3_2_11_2
  doi: 10.1056/NEJMoa022287
– ident: e_1_3_2_19_2
  doi: 10.1161/01.cir.0000082924.75945.48
– ident: e_1_3_2_4_2
  doi: 10.1007/s10067-004-0987-3
– ident: e_1_3_2_5_2
  doi: 10.1371/journal.pmed.0020354
– ident: e_1_3_2_20_2
  doi: 10.1136/ard.2007.082131
– ident: e_1_3_2_15_2
  doi: 10.1096/fj.04-2727fje
– ident: e_1_3_2_9_2
  doi: 10.1002/art.1780230510
– ident: e_1_3_2_17_2
  doi: 10.1186/ar2165
– ident: e_1_3_2_2_2
  doi: 10.1016/S0140-6736(04)16864-5
– ident: e_1_3_2_8_2
  doi: 10.1002/art.22035
– ident: e_1_3_2_12_2
  doi: 10.1016/j.ejphar.2007.01.045
– ident: e_1_3_2_18_2
  doi: 10.1126/science.275.5302.964
– ident: e_1_3_2_6_2
  doi: 10.2217/14796694.2.1.83
– ident: e_1_3_2_13_2
  doi: 10.1007/s11926-008-0031-8
– ident: e_1_3_2_22_2
  doi: 10.1002/art.21952
– ident: e_1_3_2_21_2
  doi: 10.1161/01.atv.0000114236.77009.06
– ident: e_1_3_2_14_2
  doi: 10.1016/j.radonc.2006.07.021
– ident: e_1_3_2_16_2
  doi: 10.1074/jbc.M304736200
– ident: e_1_3_2_3_2
  doi: 10.1002/art.11310
– ident: e_1_3_2_1_2
  doi: 10.1007/s12016-007-8009-2
– volume: 15
  start-page: 202
  year: 1988
  ident: e_1_3_2_10_2
  publication-title: J Rheumatol
– ident: e_1_3_2_7_2
  doi: 10.1016/S0140-6736(04)16853-0
– ident: e_1_3_2_23_2
  doi: 10.1038/sj.onc.1208421
– reference: 14551207 - J Biol Chem. 2004 Jan 9;279(2):1513-25
– reference: 15349798 - Clin Rheumatol. 2005 Apr;24(2):111-6
– reference: 9020076 - Science. 1997 Feb 14;275(5302):964-7
– reference: 16802364 - Arthritis Rheum. 2006 Jul;54(7):2250-62
– reference: 12860902 - Circulation. 2003 Jul 29;108(4):457-63
– reference: 14613262 - Arthritis Rheum. 2003 Nov;48(11):3023-30
– reference: 15824087 - FASEB J. 2005 Jun;19(8):974-6
– reference: 17767740 - Arthritis Res Ther. 2007;9 Suppl 2:S2
– reference: 15313340 - Lancet. 2004 Aug 14-20;364(9434):561-2
– reference: 3361530 - J Rheumatol. 1988 Feb;15(2):202-5
– reference: 16916558 - Radiother Oncol. 2006 Aug;80(2):199-206
– reference: 27161125 - Acta Haematol. 2016;136(2):65-70
– reference: 15688014 - Oncogene. 2005 Mar 31;24(14):2317-29
– reference: 14699017 - Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):288-93
– reference: 16250671 - PLoS Med. 2005 Dec;2(12):e354
– reference: 16556075 - Future Oncol. 2006 Feb;2(1):83-9
– reference: 16868984 - Arthritis Rheum. 2006 Aug;54(8):2605-15
– reference: 17320859 - Eur J Pharmacol. 2007 May 7;562(1-2):111-8
– reference: 7378088 - Arthritis Rheum. 1980 May;23(5):581-90
– reference: 18638425 - Curr Rheumatol Rep. 2008 Jul;10(3):183-8
– reference: 12584367 - N Engl J Med. 2003 Feb 13;348(7):593-600
– reference: 18174219 - Ann Rheum Dis. 2008 Oct;67(10):1455-60
– reference: 15313361 - Lancet. 2004 Aug 14-20;364(9434):603-10
– reference: 18064573 - Clin Rev Allergy Immunol. 2007 Oct;33(1-2):107-12
SSID ssj0006375
Score 2.2478883
Snippet Background— Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to...
Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2156
SubjectTerms Adult
Aged
Apoptosis
Apoptosis Regulatory Proteins - biosynthesis
Bcl-2-Like Protein 11
Cells, Cultured
Colony-Forming Units Assay - methods
Endothelial Cells - metabolism
Endothelial Cells - pathology
Female
Forkhead Box Protein O3
Forkhead Transcription Factors - metabolism
Humans
Immunoglobulin G - metabolism
Male
Membrane Proteins - biosynthesis
Middle Aged
Proto-Oncogene Proteins - biosynthesis
Proto-Oncogene Proteins c-akt - metabolism
Regeneration
Scleroderma, Systemic - metabolism
Scleroderma, Systemic - pathology
Serum - metabolism
Stem Cells - metabolism
Stem Cells - pathology
Transcription, Genetic
Up-Regulation
Title Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum–Induced Apoptosis in Endothelial Progenitor Cells
URI https://www.ncbi.nlm.nih.gov/pubmed/18981303
https://www.proquest.com/docview/69802362
https://pubmed.ncbi.nlm.nih.gov/PMC3719010
Volume 118
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1524-4539
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006375
  issn: 0009-7322
  databaseCode: KQ8
  dateStart: 19500101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1524-4539
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0006375
  issn: 0009-7322
  databaseCode: DIK
  dateStart: 19500101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1524-4539
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0006375
  issn: 0009-7322
  databaseCode: GX1
  dateStart: 19500101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIlVcELQ8wnORUC-RS2yv184xjRoFSBtAiRS4WOv1hkRt7JDYSOXEX-GfMuO30yAKF8vaZL2W5_PszHjmG0JeGx4zkAVGazPR0eB8pnmGZWhcSpsxGyCdFAqfnfPBhL2bWtNG41claymOvGP5Y2ddyf9IFcZArlgl-w-SLS4KA3AO8oUjSBiON5MxbjT5a58w9H_NunGhDXiyWKJx2R9NR2ZSedXqXkRpqQgGWzdwsTV2QluKFtxtvNTAPY8xHUCswlUUIlMJ8okEPhZpXWJkHZO5FOqAdQsD_puqZdtbrGW--I4OP5WIw5d5nMRc52F8IbKNs2rT14LUn9MA7cmiAPGH8Dsgq0xuyj5s5ZELB0v46srWYBqzUjKjY7VjLNfQ5aw4r6guFG7KS359J-C4E_TefupNhimv8KCLCZXHoKFSctQt9u3zkdufDIfu-HQ6Plp907AxGX7Az7q03CK3DZtzbJLx_mNJSM_NhMu5uO198ipb_c0f166bQNf8mu303Iq9M75H7maOCu2mqLtPGio4IIfdQETh8ooe0SR1OPkmc0D2z7IMjUPycwuTtMQkDWcUMEm9K5pikgImKWCS5pikFUzSGiZpgUm6CGgFk7TEJE0w-YBM-qfj3kDLunxoEqzvCFSDyR1D6AY2IuCm7kswSm2lO74lwJptK084nPlwZs1UW9m-hWWCpmPMPCm58syHZC8IA_WYUHB-JVOmKXzmMKnrHvjCDhO-ZB64KaZoEid_8K7MKPCxE8ulm7jCXHfrMkP2XDeVWZMYxdRVygNzk0kvc-m6oLXxKYhAhfHG5R0kXuRGkzxKZV1e1Ok4aFc2iV1DQfEH5IOv_xIs5gkvvGmjdd9-8tdVn5I75fv4jOxF61g9B9s68l4k6P4N0B3QQA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcriptional+regulation+of+Bim+by+FOXO3a+and+Akt+mediates+scleroderma+serum-induced+apoptosis+in+endothelial+progenitor+cells&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Zhu%2C+Shoukang&rft.au=Evans%2C+Sarah&rft.au=Yan%2C+Bin&rft.au=Povsic%2C+Thomas+J&rft.date=2008-11-18&rft.issn=1524-4539&rft.eissn=1524-4539&rft.volume=118&rft.issue=21&rft.spage=2156&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.108.787200&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon